Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.39831 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.38057 | 16 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.38532 | 16 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.3141 | 15 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.40723 | 19 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.44301 | 16 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.40435 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.36137 | 15 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.3497 | 15 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.36857 | 15 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.37034 | 16 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.35592 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.40356 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.37312 | 15 |